Parallax Volatility Advisers
IBB icon

Parallax Volatility Advisers’s iShares Biotechnology ETF IBB Stock Holding History

Parallax Volatility Advisers’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,800
Closed -$2.25M – 1704
2025
Q2 		$2.25M Hold
17,800
– – 0.01% 840
2025
Q1 		$2.28M Sell
17,800
-7,400
-29% -$1M 0.01% 836
2024
Q4 		$3.33M Sell
25,200
-48,900
-66% -$6.87M 0.01% 981
2024
Q3 		$10.8M Buy
74,100
+28,400
+62% +$4.11M 0.02% 526
2024
Q2 		$6.27M Buy
45,700
+26,900
+143% +$3.59M 0.01% 636
2024
Q1 		$2.58M Sell
18,800
-45,900
-71% -$6.27M 0.01% 948
2023
Q4 		$8.79M Buy
+64,700
New +$7.89M 0.02% 625
2023
Q3 		– Sell
-12,300
Closed -$1.56M – 2425
2023
Q2 		$1.56M Sell
12,300
-400
-3% -$52K ﹤0.01% 1227
2023
Q1 		$1.64M Sell
12,700
-565,200
-98% -$74M ﹤0.01% 1298
2022
Q4 		$75.9M Buy
577,900
+59,000
+11% +$7.62M 0.12% 194
2022
Q3 		$60.7M Buy
518,900
+219,700
+73% +$27.3M 0.09% 228
2022
Q2 		$35.2M Buy
299,200
+73,800
+33% +$8.76M 0.03% 347
2022
Q1 		$29.4M Sell
225,400
-40,300
-15% -$5.25M 0.02% 391
2021
Q4 		$40.6M Buy
265,700
+265,600
+265,600% +$41.1M 0.05% 272
2021
Q3 		$16K Sell
100
-333,100
-100% -$56.1M ﹤0.01% 1879
2021
Q2 		$54.5M Buy
+333,200
New +$51.3M 0.07% 176
2021
Q1 		– Sell
-390,000
Closed -$59.1M – 1562
2020
Q4 		$59.1M Buy
390,000
+134,000
+52% +$19.2M 0.06% 265
2020
Q3 		$34.7M Sell
256,000
-22,700
-8% -$3.08M 0.03% 524
2020
Q2 		$38.1M Buy
278,700
+174,200
+167% +$22.2M 0.04% 329
2020
Q1 		$11.3M Buy
104,500
+1,400
+1% +$161K 0.01% 560
2019
Q4 		$12.4M Buy
103,100
+101,700
+7,264% +$11.3M 0.01% 582
2019
Q3 		$140K Sell
1,400
-134,100
-99% -$14M ﹤0.01% 1921
2019
Q2 		$14.8M Buy
135,500
+118,100
+679% +$12.6M 0.02% 433
2019
Q1 		$1.95M Buy
17,400
+12,700
+270% +$1.39M ﹤0.01% 1012
2018
Q4 		$458K Sell
4,700
-185,000
-98% -$19.6M ﹤0.01% 1527
2018
Q3 		$23.1M Sell
189,700
-157,000
-45% -$18.5M 0.03% 258
2018
Q2 		$38.1M Sell
346,700
-78,300
-18% -$8.37M 0.05% 154
2018
Q1 		$45.4M Buy
425,000
+149,500
+54% +$16.6M 0.06% 147
2017
Q4 		$29.4M Buy
275,500
+92,500
+51% +$9.89M 0.04% 202
2017
Q3 		$20.3M Sell
183,000
-92,700
-34% -$9.91M 0.03% 264
2017
Q2 		$28.5M Buy
275,700
+40,200
+17% +$3.96M 0.06% 196
2017
Q1 		$23M Buy
+235,500
New +$22.5M 0.05% 224
2016
Q2 		– Sell
-6,000
Closed -$522K – 2946
2016
Q1 		$522K Sell
6,000
-294,000
-98% -$26.3M ﹤0.01% 1433
2015
Q4 		$33.8M Buy
300,000
+150,000
+100% +$16.3M 0.07% 183
2015
Q3 		$15.2M Sell
150,000
-48,000
-24% -$5.76M 0.03% 316
2015
Q2 		$24.4M Buy
+198,000
New +$23.7M 0.05% 253
2014
Q3 		– Sell
-54,000
Closed -$4.63M – 4275
2014
Q2 		$4.63M Sell
54,000
-25,200
-32% -$1.99M 0.02% 506
2014
Q1 		$6.24M Buy
+79,200
New +$6.6M 0.04% 342

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Parallax Volatility Advisers's IBB Position: Q1 2026 in Review

Parallax Volatility Advisers sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 13,526 shares — an estimated $2.28M sold.

Parallax Volatility Advisers first reported a position in IBB in Q2 2014 and held it in 43 quarters. The position peaked at $29.4M in Q4 2020. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Parallax Volatility Advisers reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • Parallax Volatility Advisers sold 13,526 iShares Biotechnology ETF shares in Q1 2026, an estimated $2.28M.
  • Parallax Volatility Advisers first reported a position in iShares Biotechnology ETF in Q2 2014 and held it in 43 quarters.
  • Parallax Volatility Advisers's iShares Biotechnology ETF position peaked at $29.4M in Q4 2020.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.